Literature DB >> 28482965

The diagnostic utility of pleural fluid adenosine deaminase for tuberculosis in a low prevalence area.

P Sivakumar1, L Marples2, R Breen3, L Ahmed3.   

Abstract

BACKGROUND: Pleural fluid adenosine deaminase (pfADA) is not routinely measured in patients with undiagnosed pleural effusion due to limited evidence of its diagnostic utility in areas of low tuberculosis (TB) prevalence.
METHODS: We conducted a retrospective consecutive case series analysis of all patients who underwent pfADA testing from 2009 to 2015 at a tertiary service pleural centre in south London. Using receiver operating characteristic (ROC) curve analysis, we identified the optimal threshold at which maximal sensitivity and specificity were achieved.
RESULTS: Of the 132 patients tested for pfADA, 27 had confirmed pleural TB and 105 did not, with median pfADA levels of respectively 63 IU/l (interquartile range [IQR] 47-88) and 12 IU/l (IQR 7.5-22.5). ROC curve analysis determined the optimal pfADA cut-off to be 30 IU/l, which had positive and negative predictive values of respectively 60.5% and 98.9%, 96.3% sensitivity (95%CI 0.892-1.000) and 83.8% specificity (95%CI 0.768-0.909). The calculated area under the ROC curve was 0.934 (95%CI 0.893-0.975).
CONCLUSION: A pfADA level <30 IU/l makes a diagnosis of TB highly unlikely in the South London population. Its high sensitivity and negative predictive values make pfADA a valuable screening test for excluding suspected pleural TB.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28482965     DOI: 10.5588/ijtld.16.0803

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  7 in total

1.  A Systematic Review and Meta-analysis of the Diagnostic Accuracy of Nucleic Acid Amplification Tests for Tuberculous Meningitis.

Authors:  Ali Pormohammad; Mohammad Javad Nasiri; Timothy D McHugh; Seyed Mohammad Riahi; Nathan C Bahr
Journal:  J Clin Microbiol       Date:  2019-05-24       Impact factor: 5.948

2.  Investigating the appropriate adenosine deaminase cutoff value for the diagnosis of tuberculous pleural effusion in a country with decreasing TB burden.

Authors:  Hyung Woo Kim; Kyung Hoon Kim; Ah Young Shin; Joon Young Choi; Joong Hyun Ahn; Ju Sang Kim; Woo Ho Ban; Jongyeol Oh; Jick Hwan Ha
Journal:  Sci Rep       Date:  2022-05-09       Impact factor: 4.996

3.  An uncommon cause of pleural effusion.

Authors:  Amit Panjwani; Mohamed Redha Salman
Journal:  Breathe (Sheff)       Date:  2019-06

4.  A retrospective study on the combined biomarkers and ratios in serum and pleural fluid to distinguish the multiple types of pleural effusion.

Authors:  Liyan Lin; Shuguang Li; Qiao Xiong; Hui Wang
Journal:  BMC Pulm Med       Date:  2021-03-19       Impact factor: 3.317

Review 5.  Diagnostics in Pleural Disease.

Authors:  Anand Sundaralingam; Eihab O Bedawi; Najib M Rahman
Journal:  Diagnostics (Basel)       Date:  2020-12-04

6.  Diagnostic accuracy of adenosine deaminase for pleural tuberculosis in a low prevalence setting: A machine learning approach within a 7-year prospective multi-center study.

Authors:  Alberto Garcia-Zamalloa; Diego Vicente; Rafael Arnay; Arantzazu Arrospide; Jorge Taboada; Iván Castilla-Rodríguez; Urko Aguirre; Nekane Múgica; Ladislao Aldama; Borja Aguinagalde; Montserrat Jimenez; Edurne Bikuña; Miren Begoña Basauri; Marta Alonso; Emilio Perez-Trallero
Journal:  PLoS One       Date:  2021-11-04       Impact factor: 3.240

7.  Adenosine deaminase negative pleural tuberculosis: a case report.

Authors:  Zachary H Boggs; Scott Heysell; Joshua Eby; Christopher Arnold
Journal:  BMC Infect Dis       Date:  2021-06-15       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.